Passion Vista rejoiced with Dr Vineeta Ahooja on a stupendious virtual event ANI | Updated: Jan 20, 2021 17:02 IST
New Delhi [India], January 20 (ANI/Digpu): Unified Brainz celebrated 2nd anniversary of its international magazine brand - Passion Vista with most eminent Indians in its anniversary edition The Most Admired Global Indians 2020 which was launched virtually on 9th January 2021. The spectacular event witnessed not only powerful personalities but also leading visioners from different walks of life who crafts, curates and conceptualizes to all the industries across the globe. You can move mountains! , said Chetan P. Ahooja to his six-year-old daughter. These words resonate with Dr VineetaAhooja through every endeavor in her life. Today she is a highly skilled and accomplished Cardiologist with board certifications in Internal Medicine, Cardiology, Echocardiography, Nuclear Cardiology, and Cardiac CT. Her educational journey commen
Estudio piloto canadiense sugiere que la prescripción de etilo de icosapento (VASCEPA®) podría mejorar los síntomas de la COVID-19 y reducir la inflamación
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.
Kanadische Pilotstudie deutet darauf hin, dass verschreibungspflichtiges Icosapent-Ethyl (VASCEPA®) die Symptome von COVID-19 bessern und Entzündungen reduzieren könnte
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.
(1)
TORONTO, ON, Dec. 14, 2020 /PRNewswire/ The results of a Canadian study released this weekend provides encouraging data suggesting that the prescription strength omega-3 called icosapent ethyl (VASCEPA) may reduce inflammation and improve symptoms in patients with a diagnosis of COVID-19. This study provides the first evidence of an early anti-inflammatory effect of icosapent ethyl in symptomatic COVID-19 positive outpatients - who represent the majority of patients affected by this disease in the community , said Professor Deepak L. Bhatt, Brigham and Women s Hospital and Harvard Medical School.
The study was conducted by The Canadian Medical and Surgical Knowledge Translation Research Group through an investigator-initiated grant from HLS Therapeutics and Amarin Pharmaceuticals. The study was presented by Professor Bhatt as a Late-Breaking Clinical Trial on December 12th at the National Lipid Association Conference.
Canadian pilot study suggests prescription icosapent ethyl (VASCEPA®) might improve symptoms of COVID-19 and reduce inflammation
idahostatejournal.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from idahostatejournal.com Daily Mail and Mail on Sunday newspapers.